Keep PA Medicaid Coverage of GLP-1s for Obesity

Background: After years of advocacy efforts, Pennsylvania Medical Assistance (Medicaid) coverage for these life saving medications began in 2023. Now coverage is at risk as the Pennsylvania Budget in Brief 2025-2026, includes cuts to Medical Assistance coverage of GLP-1s for the treatment of obesity.

Data shows that the cost of obesity medications is not the root of the budget problem and only a small fraction of the overall spend on the class of GLP-1s. Obesity is a complex chronic disease and people living with obesity have a right to FDA-approved medications — in the same fashion as diabetes, heart disease or cancer.

Take Action Now: Use OAC’s advocacy tool below to tell Pennsylvania’s Governor and lawmakers to keep coverage of GLP-1s for the treatment of obesity.

It’s Easy to Advocate! Use our easy automated message generator below to get started. Once you enter your information, click “next” and you’ll find a template letter to get you started. We encourage you to personalize this letter before sending by including your story and thoughts before sending.